These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 28703774)

  • 1. Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis.
    Cho H; Kang H; Lee HH; Kim CW
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
    Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
    Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic Characteristics of PD-1 and CTLA-4 Expression in Symptomatic Acute Hepatitis A.
    Cho H; Kang H; Kim CW; Kim HY; Jang JW; Yoon SK; Lee CD
    Gut Liver; 2016 Mar; 10(2):288-94. PubMed ID: 26347518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade.
    Nakamoto N; Cho H; Shaked A; Olthoff K; Valiga ME; Kaminski M; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM
    PLoS Pathog; 2009 Feb; 5(2):e1000313. PubMed ID: 19247441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4)- and Programmed Death 1 (PD-1)-Mediated Regulation of Monofunctional and Dual Functional CD4
    Rajamanickam A; Munisankar S; Dolla C; Nutman TB; Babu S
    Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31570560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.
    Nakamoto N; Kaplan DE; Coleclough J; Li Y; Valiga ME; Kaminski M; Shaked A; Olthoff K; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM
    Gastroenterology; 2008 Jun; 134(7):1927-37, 1937.e1-2. PubMed ID: 18549878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance.
    Ye B; Liu X; Li X; Kong H; Tian L; Chen Y
    Cell Death Dis; 2015 Mar; 6(3):e1694. PubMed ID: 25789969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C.
    Larrubia JR; Benito-Martínez S; Miquel J; Calvino M; Sanz-de-Villalobos E; Parra-Cid T
    World J Gastroenterol; 2009 Nov; 15(41):5129-40. PubMed ID: 19891011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults.
    Boer MC; van Meijgaarden KE; Goletti D; Vanini V; Prins C; Ottenhoff TH; Joosten SA
    Tuberculosis (Edinb); 2016 Mar; 97():163-71. PubMed ID: 26750180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis.
    Moreno-Cubero E; Larrubia JR
    World J Gastroenterol; 2016 Jul; 22(28):6469-83. PubMed ID: 27605882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation.
    Bengsch B; Martin B; Thimme R
    J Hepatol; 2014 Dec; 61(6):1212-9. PubMed ID: 25016223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral loss of CD8(+) CD161(++) TCRVα7·2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patients.
    Barathan M; Mohamed R; Vadivelu J; Chang LY; Saeidi A; Yong YK; Ravishankar Ram M; Gopal K; Velu V; Larsson M; Shankar EM
    Eur J Clin Invest; 2016 Feb; 46(2):170-80. PubMed ID: 26681320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-1 expression on CTL may be related to more severe liver damage in CHB patients with HBV genotype C than in those with genotype B infection.
    Xibing G; Xiaojuan Y; Juanhua W
    J Viral Hepat; 2013 Apr; 20(4):e1-2. PubMed ID: 23490376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus-Specific T Cells.
    Schirdewahn T; Grabowski J; Owusu Sekyere S; Bremer B; Wranke A; Lunemann S; Schlaphoff V; Kirschner J; Hardtke S; Manns MP; Cornberg M; Wedemeyer H; Suneetha PV
    J Infect Dis; 2017 Jan; 215(1):139-149. PubMed ID: 27803174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA-4 and its ligands on the surface of T- and B-lymphocyte subsets in chronic hepatitis B virus infection.
    Wongjitrat C; Sukwit S; Chuenchitra T; Seangjaruk P; Rojanasang P; Romputtan P; Srisurapanon S
    J Med Assoc Thai; 2013 Jan; 96 Suppl 1():S54-9. PubMed ID: 23724456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161
    Yong YK; Saeidi A; Tan HY; Rosmawati M; Enström PF; Batran RA; Vasuki V; Chattopadhyay I; Murugesan A; Vignesh R; Kamarulzaman A; Rajarajeswaran J; Ansari AW; Vadivelu J; Ussher JE; Velu V; Larsson M; Shankar EM
    Front Immunol; 2018; 9():472. PubMed ID: 29616020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between SNPs of Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death 1 (PD-1)and the susceptibility to chronic Hepatitis C infection in virus C-infected patients.
    Ali ESG; Bassyouni RH; Abdelaleem OO; Hassan EA; Gaber SN
    Virus Res; 2022 Mar; 310():198684. PubMed ID: 35063794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune checkpoint inhibitors for cancer treatment.
    Park J; Kwon M; Shin EC
    Arch Pharm Res; 2016 Nov; 39(11):1577-1587. PubMed ID: 27770382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.
    Fisicaro P; Valdatta C; Massari M; Loggi E; Ravanetti L; Urbani S; Giuberti T; Cavalli A; Vandelli C; Andreone P; Missale G; Ferrari C
    Gastroenterology; 2012 Dec; 143(6):1576-1585.e4. PubMed ID: 22929808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.